Alle verbonden artikelen

Will modern immunotherapies become the standard of care for advanced synchronous or metachronous cancers?

Auteurs : Kourie HR, Awada A
Jaar : 2015
Journal : Future Oncol
Volume : 11
Pagina's : 3053-5

Of art and science: is personalized medicine getting personal enough?

Auteurs : Hendlisz A
Jaar : 2015
Journal : Curr Opin Oncol
Volume : 27(4)
Pagina's : 349-50

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Auteurs : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, El Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Van den Eynde M, Maréchal R, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart-Gebhart M, Van Laethem JL, Flamen P
Jaar : 2015
Journal : BMC Cancer
Volume : 15
Pagina's : 173

Integrative proteomic and gene expression analysis identify potential biomarkers for adjuvant trastuzumab resistance: analysis from the Fin-her phase III randomized trial.

Auteurs : Sonnenblick A, Brohée S, Fumagalli D, Rothé F, Vincent D, Ignatiadis M, Desmedt C, Salgado R, Sirtaine N, Loi S, Neven P, Loibl S, Denkert C, Joensuu H, Piccart-Gebhart M, Sotiriou C
Jaar : 2015
Journal : Oncotarget
Volume : 6
Pagina's : 30306-16

Participation of Italian Cancer Centres of the Alleanza Contro Il Cancro (ACC) in the Organisation of European Cancer Institutes (OECI) Accreditation and Designation program: a successful first national initiative.

Auteurs : Oberst S, Boomsma F, Lombardo C, Docter M, Blaauwgeers H, De Paoli P, de Valeriola D, Paradiso A, Saghatchian M
Jaar : 2015
Journal : Tumori
Volume : 101 Suppl 1
Pagina's : 0

Subclonal diversification of primary breast cancer revealed by multiregion sequencing.

Auteurs : Yates LR, Gerstung M, Knappskog S, Desmedt C, Gundem G, Van Loo P, Aas T, Alexandrov LB, Larsimont D, Davies H, Li Y, Ju YS, Ramakrishna M, Haugland HK, Lilleng PK, Nik-Zainal S, McLaren S, Butler A, Martin S, Glodzik D, Menzies A, Raine K, Hinton J, Jones D, Mudie LJ, Jiang B, Vincent D, Greene-Colozzi A, Adnet PY, Fatima A, Maetens M, Ignatiadis M, Stratton MR, Sotiriou C, Richardson AL, Lønning PE, Wedge DC, Campbell PJ
Jaar : 2015
Journal : Nat. Med.
Volume : 21(7)
Pagina's : 751-9

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy.

Auteurs : Azim HA, Peccatori FA, Brohée S, Branstetter D, Loi S, Viale G, Piccart-Gebhart M, Dougall WC, Pruneri G, Sotiriou C
Jaar : 2015
Journal : Breast Cancer Res
Volume : 17
Pagina's : 24

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.

Auteurs : Ignatiadis M, Lee M, Jeffrey SS
Jaar : 2015
Journal : Clin Cancer Res
Volume : 21
Pagina's : 4786-800

Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab: A Secondary Analysis of the NeoALTTO Trial.

Auteurs : Salgado R, Denkert C, Campbell C, Savas P, Nucifero P, Aura C, de Azambuja E, Eidtmann H, Ellis CE, Baselga J, Piccart-Gebhart M, Michiels S, Bradbury I, Sotiriou C, Loi S
Jaar : 2015
Journal : JAMA Oncol
Volume : 1(4)
Pagina's : 448-54

Guidelines for time-to-event end point definitions in breast cancer trials: results of the DATECAN initiative (Definition for the Assessment of Time-to-event Endpoints in CANcer trials)†.

Auteurs : Gourgou-Bourgade S, Cameron D, Poortmans P, Asselain B, Azria D, Cardoso F, + collaborators (among others :, Dal Lago L, de Azambuja E, Dabakuyo-Yonli TS
Jaar : 2015
Journal : Ann Oncol
Volume : 26(5)
Pagina's : 873-879.

Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.

Auteurs : Fumagalli D, Gacquer D, Rothé F, Lefort A, Libert F, Brown D, Kheddoumi N, Shlien A, Konopka T, Salgado R, Larsimont D, Polyak K, Willard-Gallo K, Desmedt C, Piccart-Gebhart M, Abramowicz M, Campbell PJ, Sotiriou C, Detours V
Jaar : 2015
Journal : Cell Rep
Volume : 13
Pagina's : 277-89

Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up.

Auteurs : Dallaudière B, Kerger J, Malghem J, Galant C, Lecouvet FE
Jaar : 2015
Journal : Acta Radiol Open
Volume : 4(2)
Pagina's : 2047981614552217

Belgian Society of Medical oncology (BSMO - task force on breast cancer survivorship)

Auteurs : de Azambuja E, Azim HA, Buisseret L, Langenaeken C, Tkint de Roodenbeke D
Jaar : 2014
Journal : Belgian J Medical Oncology
Volume : 7(5)
Pagina's : 142-155

Breast cancer control in China: challenges and opportunities of the use of population-based routine data studies.

Auteurs : Pinto AC, Canário R, Fidalgo P
Jaar : 2014
Journal : J Thorac Dis
Volume : 6(9)
Pagina's : 1167-9

A randomized controlled phase II trial of a novel composition of paclitaxel embedded into neutral and cationic lipids targeting tumor endothelial cells in advanced triple-negative breast cancer (TNBC).

Auteurs : Awada A, Bondarenko IN, Bonneterre J, Nowara E, Ferrero JM, Bakshi AV, Wilke C, Piccart-Gebhart M
Jaar : 2014
Journal : Ann Oncol
Volume : 25(4)
Pagina's : 824-31

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2).

Auteurs : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C, + collaborators (among others :, Winer A
Jaar : 2014
Journal : Breast
Volume : 23(5)
Pagina's : 489-502

What is your diagnosis ?

Auteurs : de Azambuja E
Jaar : 2014
Journal : Belgian J Medical Oncology
Volume : 8(1)
Pagina's : 21-22

Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of (WT)BRAF/(WT)NRAS melanoma cells to vemurafenib.

Auteurs : Krayem M, Journe F, Wiedig M, Morandini R, Sales F, Awada A, Ghanem G
Jaar : 2014
Journal : Eur. J. Cancer
Volume : 50(7)
Pagina's : 1310-20

The landscape of medical oncology in Europe by 2020.

Auteurs : de Azambuja E, Ameye L, Paesmans M, Zielinski CC, Piccart-Gebhart M, Preusser M
Jaar : 2014
Journal : Ann Oncol
Volume : 25(2)
Pagina's : 525-8

ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Auteurs : Cardoso F, Costa A, Norton L, Senkus E, Aapro M, André F, Barrios CH, Bergh J, Biganzoli L, Blackwell KL, Cardoso MJ, Cufer T, El Saghir N, Fallowfield L, Fenech D, Francis P, Gelmon K, Giordano SH, Gligorov J, Goldhirsch A, Harbeck N, Houssami N, Hudis C, Kaufman B, Krop I, Kyriakides S, Lin UN, Mayer M, Merjaver SD, Nordström EB, Pagani O, Partridge A, Penault-Llorca F, Piccart-Gebhart M, Rugo H, Sledge G, Thomssen C
Jaar : 2014
Journal : Ann Oncol
Volume : 25(10)
Pagina's : 1871-88